Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Human psychology and social media may be to blame for the spread of negative attitudes toward vaccines.
Two prominent HIV researchers, including HIV co-discoverer Françoise Barré-Sinoussi, call for revising the way cure research is conducted.
Specific variations in personal genes among study participants played a part in determining the efficacy of an HIV vaccine that was moderately...
A British pilot study of PrEP among high-risk men who have sex with men (MSM) and among transgender women showed high efficacy for Truvada.
CDC researchers have estimated how well condoms and PrEP prevent HIV in gay and bisexual men. How much faith can be placed in these figures?
Men and transgender women who have sex with men and who took Truvada as PrEP in a recent trial were totally protected against HIV if they adhe...
The single-pill, once-daily antiretroviral therapy Stribild is as effective as both Atripla and a Reyataz plus Truvada combo.
New research shows Stribild, a.k.a. the Quad, is as effective and safe as Atripla in those who don’t adhere perfectly to their regimens.
Dolutegravir, an experimental once-daily integrase inhibitor being developed by ViiV Healthcare and Shionogi, combined with Epzicom, appears t...
ViiV Healthcare’s experimental integrase inhibitor dolutegravir (S/GSK-572) “compares favorably” with efavirenz (found in Sustiva...
Committee voted against recommending approval of a novel patch applied to soles of the feet to remedy pain associated with neuropathy in...
Antiretroviral drug regimens containing Norvir (ritonavir)-boosted Reyataz appear to work just as well for women, compared with men, in...
Merck’s integrase inhibitor Isentress works as well as mainstay therapy efavirenz in HIV-positive individuals starting first time treatment
The efficacy of Janssen Therapeutics’ Edurant (rilpivirine) is similar to that of Sustiva (efavirenz) over two years of treatment
Replacing Norvir boosted protease inhibitor with Isentress may be an option with improvements in blood lipid levels for HIV-positive
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.